Category: Pharmaceuticals
Experimental dengue vaccine provides immunity for over four years
A dengue vaccine candidate developed by Takeda Pharmaceutical (Takeda), TAK-003, has shown promising results in a Phase 3 trial, providing continued protection against dengue fever through 4.5 years (54 months) post-vaccination. Data revealed TAK-003 prevented 61% of symptomatic dengue cases […]
Complete cancer remission in drug trial development
A small clinical trial of the drug dostarlimab in the US has virtually rid each of its 18 participants of colorectal cancer, one of the most dangerous common cancers known to man. Doctors, stunned with the effectiveness of the drug, […]
Dual-action drug treats diabetes and obesity
A new type of treatment called the Mounjaro (tirzepatide) shot has just been approved by the US Food and Drug Administration (FDA) for type 2 diabetes. The once-weekly injection for adults was found to be effective at controlling blood sugar […]
EU drug regulator hopes for approval for adaptive coronavirus vaccines this year
The European Medicines Agency (EMA) is hoping to have access to multi-protection vaccines, including one that is able to address several coronavirus variants, by September 2022. Vaccine developers are currently investigating whether shots that target just one variant offer advantages […]
Fourth COVID-19 vaccine dose authorised for Americans over 50
The Head of the US Food and Drug Administration (FDA)’s Center for Biologics Evaluation and Research, Peter Marks, has encouraged getting a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine for increased protection for high-risk persons. The […]
Pfizer, UNICEF to supply Paxlovid COVID-19 oral treatment for low-, middle-income countries
Pfizer Inc. (Pfizer) has announced an agreement with UNICEF to supply nearly 4 million treatment courses of its COVID-19 oral treatment to 95 low- and middle-income countries. The COVID-19 oral treatment, Paxlovid (nirmatrelvir tablets and ritonavir tablets), will be given […]
Experimental mRNA-based HIV vaccines enter human trials
Biotechnology company Moderna Inc. (Moderna) has commenced a Phase 1 human trial testing three different mRNA vaccines that targets HIV (human immunodeficiency virus). The success of the “safe and highly effective” COVID-19 vaccines enabled this opportunity, run in association with […]
Neuroscientists identify new drug target to reduce anxiety
A team from the University of Bristol’s School of Physiology, Pharmacology and Neuroscience, UK, have discovered a key pathway in the brain which leads to anxious and fearful behaviour such as “freezing.” Anxiety and certain psychological disorders, which affect an […]
GeoVax experimental vaccine advances in clinical trials
A vaccine is currently in development that packs a double punch against the coronavirus. GeoVax Labs Inc.’s (GeoVax) experimental vaccine, GEO-CM04S1, which induces immune responses specific to the spike protein on the surface of the virus and the “nucleocapsid,” or […]
